Wells Fargo’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.91M Buy
2025
Q2
$1.1M Sell
2025
Q1
$3.19M Buy
2024
Q4
$3.1M Buy
2024
Q3
$758K Buy
2024
Q2
$579K Buy
2024
Q1
$583K Buy
2023
Q4
$512K Sell
2023
Q3
$1.87M Buy
2023
Q2
$846K Buy
2023
Q1
$591K Buy
2022
Q4
$15.6K Buy
2022
Q3
$19K Buy
2022
Q2
$12K Sell
2022
Q1
$71K Sell
2021
Q4
$868K Buy
2021
Q3
$0 Buy